Mi‐Ae Jang

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome”.

Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome

Molecular Therapy(2024)10.1016/j.ymthe.2024.05.034

N/A

0.508DataRank · unranked

14 citations

Yan Xiong, Mi‐Ae Jang, Kwang‐Su Park, Meaghan Donahue, Julia Velez +3 more

Mechanism of EHMT2-mediated genomic imprinting associated with Prader-Willi syndrome

Nature Communications(2025)10.1038/s41467-025-61156-8

N/A

0DataRank · unranked

5 citations

Yubao Cheng, Jaechul Lim, Mi‐Ae Jang, Emily Forrest, Yuna Kim +10 more